September 10, 2021
Metformin is proving to be quite useful in the fight against COVID-19.
A paper from 2017 brilliantly displays the multiple beneficial roles of METFORMIN. Interestingly, it is especially useful with its proven ANTI-SENESCENCE effects on OLFACTORY (sense of smell) CELLS. What is the most intriguing finding is that Metformin not only causes cells that should die, to die, but also removes Senescent cells (yes, the two mechanisms, are of course, related, but there are fine differences between them, as well).
Simultaneously, they noted increased cell viability, reduced expression of markers associated with cellular senescence and a decreased amount of reactive oxygen species. Obtained results indicate that metformin may exert antioxidant, anti-apoptotic and senolytic action on Olfactory Ensheathing Cells expanded ex vivo.
I don’t believe most people realize that the loss of smell (and taste for many) in COVID-19 IS NOT NORMAL. It is a very different mechanism than the one that causes the same symptom(s) in the common cold or the flu.
In fact, this type of anosmia (loss of sense of smell) is very common as a PRECURSOR to ALZHEIMER’S, PARKINSONS and other NEURODEGENERATIVE DISEASES.
The most shocking statistic I could find? A study has suggested that, for older adults, being unable to identify smells could indicate mortality within 5 years. Of the participants who had failed the first
smelling test, 39% had died before the follow-up survey 5 years later. In contrast, 19% of participants with moderate smell loss and 10% of those with a good sense of smell died during the same period.
Another paper notes (and supports my parallel hypothesis that the Spike Protein induces autoimmunity via molecular mimicry) this
relation of anosmia to autoimmune diseases, which are also diseases of senescence.
We previously showed that olfactory dysfunction can be seen in a number of autoimmune diseases such as: SLE, multiple sclerosis and myasthenia gravis (MG). As for the above mentioned clear association between autoimmunity and the current COVID-19 pandemic, the recent observation of high prevalence of olfactory dysfunction, especially in the early presentation in COVID-19 patients – is not surprising.
A CAMPAIGN OF FALSE CALM AND REASSURANCE
Please take a moment to reflect. How many times have you read a phrase like “It should come as no surprise” in relation to the myriad bizarre COVID symptoms, which have been (reluctantly) revealed to the public, as they become impossible to ignore?
The evidence is overwhelming and right in front of our eyes. Yet our doctors ignore it and fall in line with an increasingly (obvious) nefarious plan to drive the majority of those alive to a very, very early grave.
Is it our doctors knowing, willful participation in this operation that is to blame? Is it their inability to think for themselves? Their superiors? National? Global? Is it simply threat of loss of job?
Do we now have to sue our doctors for ignoring evidence that what they “prescribe” for us may harm us? If our doctors will not protect us,
or are complicit in our deaths, what else is there to do? What does that say about our future, regardless?
SARS-CoV-2, the autoimmune virus
COVID-19 Affects Sense of Smell Differently thank Colds, Flu
Is loss of smell a ‘harbinger of death’?
What Can Cause a Loss of Taste and Smell?
Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels—An Ex Vivo Study